XML 76 R43.htm IDEA: XBRL DOCUMENT v3.25.0.1
Stock-based Compensation (Tables)
12 Months Ended
Dec. 31, 2024
Share-Based Payment Arrangement [Abstract]  
Schedule of Activity Under Restricted Stock Units

Restricted Stock Units

 

 

 

Number of Units
 (in thousands)

 

 

Weighted-Average
Grant Date Fair Value per Unit

 

Balance at December 31, 2023

 

 

6,933

 

 

$

2.46

 

Assumed through acquisition

 

 

2,970

 

 

 

2.00

 

Granted

 

 

10,850

 

 

 

2.20

 

Vested

 

 

(5,332

)

 

 

2.29

 

Forfeited

 

 

(2,032

)

 

 

2.28

 

Balance at December 31, 2024

 

 

13,389

 

 

$

2.24

 

Schedule of Activity Under Stock Options

Stock Options

 

 

 

Number of
Options (in thousands)

 

 

Weighted-Average
Exercise Price
per Option

 

 

Weighted-
Average Remaining Contractual Life (in years)

 

 

Aggregate
Intrinsic
Value
(1) (in thousands)

 

Balance at December 31, 2023

 

 

9,294

 

 

$

3.62

 

 

 

8.5

 

 

 

 

Assumed through acquisition

 

 

28,184

 

 

 

4.80

 

 

 

 

 

 

 

Granted

 

 

6,697

 

 

 

2.50

 

 

 

 

 

 

 

Exercised

 

 

(715

)

 

 

2.07

 

 

 

 

 

 

 

Cancelled

 

 

(4,247

)

 

 

3.88

 

 

 

 

 

 

 

Balance at December 31, 2024

 

 

39,213

 

 

$

4.28

 

 

 

5.9

 

 

$

2.75

 

Vested at December 31, 2024

 

 

28,594

 

 

$

4.76

 

 

 

5.0

 

 

$

2.75

 

Unvested options at December 31, 2024

 

 

10,619

 

 

$

3.10

 

 

 

8.6

 

 

$

 

 

 

(1)
Aggregate intrinsic value as of December 31, 2024 was calculated as the difference between the closing price per share of the Company’s common stock on The Nasdaq Global Select Market on December 31, 2024, which was $1.75, and the exercise price of the options, multiplied by the number of in-the-money options.
Schedule of Stock-Based Compensation Determined using Black-Sholes Option-Pricing Model and Weighted Average Assumptions

The weighted average assumptions used to estimate the fair value of options granted were as follows:

 

 

Year Ended December 31,

 

 

2024

 

 

2023

 

 

2022

 

Stock options

 

 

 

 

 

 

 

 

 

Weighted average expected volatility

 

 

89.0

%

 

 

97.1

%

 

 

91.8

%

Weighted average expected term

 

6.6 years

 

 

4.7 years

 

 

4.3 years

 

Weighted average risk-free interest rate

 

 

4.4

%

 

 

3.9

%

 

 

2.6

%

Dividend yield

 

 

 

 

 

 

 

 

 

Weighted-average fair value per share

 

$

1.96

 

 

$

1.49

 

 

$

2.21

 

Schedule of Nonvested Performance-Based Units Activity

Activity under the performance-based awards was as follows:

 

 

 

Number of Units
(in thousands)

 

 

Weighted-Average
Grant Date Fair Value per Unit

 

Balance at December 31, 2023

 

 

309

 

 

$

2.42

 

PSU granted

 

 

100

 

 

 

2.25

 

Performance adjustment

 

 

(26

)

 

 

2.42

 

PSU released

 

 

(383

)

 

 

2.38

 

Balance at December 31, 2024

 

 

 

 

$

 

Schedule of Stock-Based Compensation Expense

Stock-based compensation expense is reported in the Company's consolidated statements of operations as follows (in thousands):

 

 

 

Year Ended December 31,

 

 

 

2024

 

 

2023

 

 

2022

 

Cost of product revenue

 

$

732

 

 

$

652

 

 

$

511

 

Cost of services revenue

 

 

648

 

 

 

159

 

 

 

81

 

Cost of collaboration and other revenue

 

 

3

 

 

 

 

 

 

 

Research and development expense

 

 

5,827

 

 

 

1,671

 

 

 

2,481

 

Selling, general and administrative expense

 

 

24,522

 

 

 

10,641

 

 

 

11,807

 

Total stock-based compensation expense

 

$

31,732

 

 

$

13,123

 

 

$

14,880